IPO / Finance

IPO Watch: Tocagen A Brainy Play?

From RTT - IPOs
March 13, 2017 - 6:16pm
Gene therapy company Tocagen has filed for its initial public offering to fund clinical development of its experimental treatment for brain cancer.


Continue reading this article »